Anfibatide Phase Ib-IIa Clinical Trial

• Status: Completed
• Trial end date: 2015-07-01

Summary

Investigate the safety and efficacy of Anfibatide in non-ST segment myocardial infarction patients

• Phase: Phase 1/Phase 2

Details

• Lead Sponsor: Lee's Pharmaceutical Limited